Clinical Trials Directory

Trials / Completed

CompletedNCT02921321

Pilot Study of Cardiac MR in Patients With Muscular Dystrophy

Pilot Study of Cardiac Magnetic Resonance in Patients With Muscular Dystrophy

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Children's National Research Institute · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Not accepted

Summary

Muscular Dystrophy can affect the skeletal muscles and also the heart and breathing muscles, causing significant morbidity and mortality. As patients are now living longer, treatment of muscular dystrophies involves drugs that help improve heart function. However, better types of heart imaging studies are needed to understand how these treatments work. Researchers want to improve heart imaging to identify earlier indicators of heart dysfunction in muscular dystrophy patients and how these are changed by medical treatment. The new imaging indicators will also help identify candidates for entry into future clinical trials.

Detailed description

Cardiomyopathy causes significant morbidity and mortality in multiple forms of muscular dystrophy affecting children, including Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) and subtypes of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Pharmaceutical treatments for the cardiomyopathy of muscular dystrophy, including angiotensin-converting enzyme (ACE) inhibition and beta-adrenergic receptor blockade, afford significant benefit and demonstrate cardiac remodeling in clinical studies. Further studies are needed to identify and characterize more sensitive indicators of cardiac dysfunction in muscular dystrophy subjects to better stratify subjects for entry into clinical protocols.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2024-12-09
Completion
2024-12-09
First posted
2016-10-03
Last updated
2024-12-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02921321. Inclusion in this directory is not an endorsement.